Karen M. Alexander
Association of FcγRIIa R131H polymorphism with idiopathic pulmonary fibrosis severity and progression
Alexander, Karen M.; Wallace, William A; Murchison, John T.; Hart, Simon P.; Bournazos, Stylianos; Grinfeld, Jacob; Alexander, Karen M; Murchison, John T; Wallace, William A.; McFarlane, Pauline; Hirani, Nikhil; Simpson, A. John; Dransfield, Ian; Hart, Simon P
Authors
William A Wallace
John T. Murchison
Simon P. Hart
Stylianos Bournazos
Jacob Grinfeld
Karen M Alexander
John T Murchison
William A. Wallace
Pauline McFarlane
Nikhil Hirani
A. John Simpson
Ian Dransfield
Dr Simon Hart S.Hart@hull.ac.uk
Reader in Respiratory Medicine
Abstract
Background: A significant genetic component has been described for idiopathic pulmonary fibrosis (IPF). The R131H (rs1801274) polymorphism of the IgG receptor FcγRIIa determines receptor affinity for IgG subclasses and is associated with several chronic inflammatory diseases. We investigated whether this polymorphism is associated with IPF susceptibility or progression.Methods: In a case-control study, we compared the distribution of FcγRIIa R131H genotypes in 142 patients with IPF and in 218 controls using allele-specific PCR amplification.Results: No differences in the frequency of FcγRIIa genotypes were evident between IPF patients and control subjects. However, significantly impaired pulmonary function at diagnosis was observed in HH compared to RR homozygotes, with evidence of more severe restriction (reduced forced vital capacity (FVC)) and lower diffusing capacity for carbon monoxide (DL CO ). Similarly, increased frequency of the H131 allele was observed in patients with severe disease (DL CO < 40% predicted) (0.53 vs. 0.38; p = 0.03). Furthermore, the H131 allele was associated with progressive pulmonary fibrosis as determined by > 10% drop in FVC and/or > 15% fall in DL CO at 12 months after baseline (0.48 vs. 0.33; p = 0.023).Conclusions: These findings support an association between the FcγRIIa R131H polymorphism and IPF severity and progression, supporting the involvement of immunological mechanisms in IPF pathogenesis. © 2010 Bournazos et al; licensee BioMed Central Ltd.
Citation
Bournazos, S., Grinfeld, J., Alexander, K. M., Murchison, J. T., Wallace, W. A., McFarlane, P., …Hart, S. P. (2010). Association of FcγRIIa R131H polymorphism with idiopathic pulmonary fibrosis severity and progression. BMC Pulmonary Medicine, 10(1), Article ARTN 51. https://doi.org/10.1186/1471-2466-10-51
Journal Article Type | Article |
---|---|
Acceptance Date | Oct 7, 2010 |
Online Publication Date | Oct 7, 2010 |
Publication Date | Oct 7, 2010 |
Publicly Available Date | Oct 27, 2022 |
Journal | BMC.Pulm.Med. |
Electronic ISSN | 1471-2466 |
Publisher | Springer Verlag |
Peer Reviewed | Peer Reviewed |
Volume | 10 |
Issue | 1 |
Article Number | ARTN 51 |
DOI | https://doi.org/10.1186/1471-2466-10-51 |
Keywords | Association; CAPACITY; diagnosis; Disease; Genotype; Idiopathic Pulmonary Fibrosis; Inflammation; methods; Patients; Research; Research Support |
Public URL | https://hull-repository.worktribe.com/output/423551 |
Files
Article.pdf
(433 Kb)
PDF
Publisher Licence URL
http://creativecommons.org/licenses/by/2.0
Copyright Statement
© 2010 Bournazos et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative<br />
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and<br />
reproduction in any medium, provided the original work is properly cited.
You might also like
Foundations of respiratory medicine
(2018)
Book